Old API Wind-down Ltd - Ordinary Shares ARLZQ

Another Goldman article on SA

[kuatolives]

https://seekingalpha.com/article/4023305-pleasant-surprises-ahead-aralez-pharmaceuticals-shareholders

Wit Brilinta failing its Phase 3, looks like the door is open for Zontivity.

[Floridas2000]

Thanks.  I liked this summary. Valuation Based upon the foregoing, I am valuing Aralez at between $1.1 and $1.5 billion. Taking into account Aralez's 65.4 million outstanding shares, that works out to a valuation equal to approximately $16.80-22.90 per share. I expect the market may not start to appreciate Aralez's value until mid to late 2017 when Yosprala sales begin to